相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Real-Life Study of the Benefit of Concomitant Radiotherapy with Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma (cSCC): A Retrospective Cohort Study
Barbara Bailly-Caille et al.
CANCERS (2023)
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel
Itamar Averbuch et al.
FRONTIERS IN ONCOLOGY (2023)
Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients
Agata Rembielak et al.
JOURNAL OF GERIATRIC ONCOLOGY (2023)
Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers
Laura Pawlik et al.
CANCERS (2023)
Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients—A Comparison between Different Immunomodulating Conditions
Ofir Zavdy et al.
Cancers (2023)
The Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma
Chia Yuen Chong et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2023)
Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience in a Monographic Oncology Center
E. Ríos-Viñuela et al.
Actas Dermo-Sifiliograficas (2022)
Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma
Paolo A. Ascierto et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry
Maximilian Haist et al.
CANCERS (2022)
Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response
Enrico Zelin et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3
M. R. Migden et al.
ANNALS OF ONCOLOGY (2022)
CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting
G. Rabinowits et al.
ANNALS OF ONCOLOGY (2022)
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
Alice Baggi et al.
EUROPEAN JOURNAL OF CANCER (2021)
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy
Sabino Strippoli et al.
FRONTIERS IN ONCOLOGY (2021)
Real world safety outcomes using cemiplimab for cutaneous squamous cell carcinoma
Julie Valentin et al.
JOURNAL OF GERIATRIC ONCOLOGY (2021)
Cemiplimab-rwlc in advanced cutaneous squamous cell carcinoma: real-world experience in a French dermatology department
T. Guillaume et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma
Michael R. Migden et al.
FUTURE ONCOLOGY (2020)
Cutaneous squamous cell carcinoma in the organ transplant recipient
Kristin Bibee et al.
ORAL ONCOLOGY (2020)
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing
Danny Rischin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Cemiplimab for advanced cutaneous squamous cell carcinoma: Real life experience
C. Hober et al.
ANNALS OF ONCOLOGY (2020)
Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world data of a retrospective, multicenter study
Martin Salzmann et al.
EUROPEAN JOURNAL OF CANCER (2020)
Using Implementation Science to Promote the Use of the G8 Screening Tool in Geriatric Oncology
Pauline Gulasingam et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Knowing the tumour microenvironment to optimise immunotherapy
M. C. Merlano et al.
ACTA OTORHINOLARYNGOLOGICA ITALICA (2019)
Guidelines of care for the management of cutaneous squamous cell carcinoma
Murad Alam et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
M. R. Migden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Frailty Consensus: A Call to Action
John E. Morley et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2013)